Wird geladen...
Factors associated with guideline-recommended KRAS testing in colorectal cancer patients: A population-based study
OBJECTIVES: Response to epidermal growth factor receptor inhibitors is poorer among Stage IV colorectal cancer (CRC) patients with KRAS mutations, thus KRAS testing is recommended prior to treatment. KRAS testing was collected by Surveillance, Epidemiology, and End Results (SEER) registries for 2010...
Gespeichert in:
| Veröffentlicht in: | Am J Clin Oncol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591083/ https://ncbi.nlm.nih.gov/pubmed/25844824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000191 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|